Intrauterine release of progesterone antagonist ZK230211 is feasible and results in novel endometrial effects: a pilot study.

Added 5422 days ago (20.07.2007)
Authors: Heikinheimo O, Vani S, Carpén O, Tapper A, Härkki P, Rutanen EM, Critchley H
PubMed id: 17636280
Read article